This phenotypically variable disorder is considered part of the PTEN hamartoma tumour syndrome spectrum disease, which also involves other genetic entities due to PTEN mutations such as Bannayan-Riley-Ruvalcaba syndrome, Proteus- and Proteus-like syndromes. The gene discussed is PTEN; the disease is Proteus-like syndrome.